Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04141462
NA

EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer

Sponsor: Centre Georges Francois Leclerc

View on ClinicalTrials.gov

Summary

5 to 10% of cancers are due to the presence of a constitutional genetic alteration. It can be inherited from parents (family form) or by accident, in the first moments of life after fertilization (sporadic form). In both cases, this genetic alteration is constitutional and transmissible to descendants. It is hereditary. When an hereditary early form is suspected, several well-known genes generally involved in genetic predispositions to cancer are found by a technique called " gene panel ". However, this analysis does not always identify the genetic predisposing factors for cancer. New techniques called "high-throughput exome sequencing (SHD-E)", allow more than the analysis of the the gene panel. These analysis allow to identify alterations in other genes that could contribute to the development of cancer. The objective of the Ex²trican study is to show, from patients with early cancer (sporadic or familial form), that this approach to exome sequencing can be effective to identify new genetic risk of cancer, when the first panel analysis of genes is negative.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

613

Start Date

2019-10-07

Completion Date

2028-04-07

Last Updated

2026-04-03

Healthy Volunteers

No

Interventions

GENETIC

blood sample

blood test

Locations (6)

CHRU Jean Minjoz

Besançon, France

Centre Georges-François Leclerc

Dijon, France

CHU de Dijon

Dijon, France

CHU de Reims

Reims, France

Polyclinique de Courlancy

Reims, France

CH de Troyes

Troyes, France